Search

Home > GRACEcast Lung Cancer Video > What is the Role of Bevacizumab in Stage IV NSCLC?
Podcast: GRACEcast Lung Cancer Video
Episode:

What is the Role of Bevacizumab in Stage IV NSCLC?
Category: Science & Medicine
Duration: 00:03:46
Publish Date: 2016-04-15 14:00:00
Description:

Dr. Jack West, Swedish Cancer Institute, discusses the anti-angiogenic agent bevacizumab (Avastin) and the trial evidence of its efficacy for non-squamous NSCLC.
Total Play: 0